AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metbay 500 Tablet PR

Prescription Icon
Prescription Required

Marketer

Bayer Zydus Pharma Pvt Ltd

Salt Composition

Metformin (500mg)

Overview Metbay 500 Tablet PR

Metformin 500mg extended-release tablets manage type 2 diabetes by regulating blood glucose, thereby mitigating severe diabetic complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, take Metformin 500mg ER with food, consistently at the same time daily. Discontinue use only under your physician's guidance. Maintaining a healthy lifestyle, including diet and exercise as prescribed, is crucial for effective diabetes management. Common side effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, stomach discomfort, headache, and decreased appetite. Hypoglycemia (low blood sugar) may occur, especially when combined with other diabetes medications, alcohol, or missed meals; regular blood sugar monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be assessed before treatment initiation. Limit alcohol consumption to reduce the likelihood of adverse reactions.

Primary Ingredients of Metbay 500 Tablet PR

The information is unavailable.

Uses of Metbay 500 Tablet PR

Managing Type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metbay 500 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Metbay 500 Tablet PR with food.

Common Side effects of Metbay 500 Tablet PR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metbay 500 Tablet PR:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Metbay 500 Tablet PR with food.

How Metbay 500 Tablet PR works:

Metformin 500mg tablets are a biguanide-class antidiabetic drug. Their mechanism involves reducing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metbay 500 Tablet PR and alcohol is dangerous.

PregnancyPregnancySAFE IF PRESCRIBED

Metbay 500 Tablet PR is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human clinical trials are scarce.

Breast feedingBreast feedingCAUTION

Metbay 500 Tablet PR necessitates careful consideration during lactation. Nursing mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from the maternal system.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Metbay 500 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Metbay 500 Tablet PR is contraindicated in patients exhibiting severe kidney disease.

LiverLiverUNSAFE

Individuals with liver impairment should likely avoid Metbay 500 Tablet PR, as its use may pose significant safety risks. Medical advice is recommended.

What if you forget to take Metbay 500 Tablet PR :

Should you forget a Metbay 500 Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metbay 500 Tablet PR

LabelValue
Type of Compound Guanidine-based hypoglycemic agent
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Metbay 500 Tablet PR

Individuals with type 2 diabetes exhibit impaired responsiveness to their body's insulin production. This leads to elevated blood glucose concentrations. Metbay 500 Tablet PR employs multiple mechanisms to lower these elevated sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in bodily tissues. This facilitates improved glucose uptake from the bloodstream. Consequently, it improves the body's natural insulin response.
Metbay 500 Tablet PR has demonstrated weight-reduction effects in overweight and obese patients. This weight loss may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience similar results. However, self-initiation of Metbay 500 Tablet PR for weight management is strongly discouraged; medical consultation is essential.
Metbay 500 Tablet PR is an initial treatment option for individuals with elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike other oral hypoglycemics, Metbay 500 Tablet PR, when used monotherapy, infrequently leads to hypoglycemia due to its mechanism of preventing excess insulin release. Beyond glycemic control, it also aids in weight management.
Metbay 500 Tablet PR is generally well-tolerated and doesn't typically induce drowsiness. Infrequently, though, it may lead to sleep disturbances or insomnia. Excessive sleepiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially in individuals with impaired kidney function. Consult your physician immediately if fatigue or somnolence develops during Metbay 500 Tablet PR use.
Administer Metbay 500 Tablet PR orally with or following a meal. Avoid crushing or chewing the tablet; ingest it whole with water. For once-daily prescriptions, consume the tablet in the morning with breakfast. For twice-daily prescriptions, take one tablet with breakfast and the second with dinner. Three times daily, take the tablets with breakfast, lunch, and dinner. Consuming Metbay 500 Tablet PR with food mitigates potential gastrointestinal distress such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's own insulin. This results in elevated blood glucose concentrations. Metbay 500 Tablet PR employs multiple mechanisms to lower these elevated blood sugar levels. Specifically, it reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances the insulin sensitivity of bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metbay 500 Tablet PR has demonstrated weight reduction in overweight and obese patients. This weight loss effect may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance might experience weight loss. However, self-initiating Metbay 500 Tablet PR for weight management is inadvisable; medical consultation is essential.
Metbay 500 Tablet PR is an initial treatment option for individuals with elevated blood glucose. This medication facilitates blood sugar regulation by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. Differing from other oral hypoglycemics, Metbay 500 Tablet PR, when used independently, infrequently leads to hypoglycemia due to its inhibition of excessive insulin secretion. Beyond glycemic control, it also aids in managing weight increase.
Metbay 500 Tablet PR is generally well-received and doesn't typically induce drowsiness. Nevertheless, in rare instances, it might lead to sleep disturbances or insomnia. Excessive sleepiness could indicate a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or somnolence develops during Metbay 500 Tablet PR use.
Administer Metbay 500 Tablet PR orally, with or following a meal. The tablets should be swallowed whole with water; do not crush or chew them. For once-daily regimens, take the tablet in the morning with breakfast. Twice-daily prescriptions should be divided, one dose in the morning and one in the evening, taken with meals. Three times daily, distribute the doses among breakfast, lunch, and dinner. Consuming Metbay 500 Tablet PR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to endogenous insulin. This results in elevated blood glucose. Metbay 500 Tablet PR employs a multifaceted approach to lower hyperglycemia. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in tissues. This facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metbay 500 Tablet PR has demonstrated weight-reduction effects in overweight and obese patients. This weight loss may also be observed in overweight or obese individuals predisposed to diabetes. Furthermore, individuals with insulin sensitivity or resistance may experience similar results. However, self-medicating with this drug for weight management is strongly discouraged; physician consultation is mandatory.
Metbay 500 Tablet PR is an initial treatment option for hyperglycemia. This medication manages blood glucose levels by enhancing insulin sensitivity, reducing hepatic glucose production, and minimizing intestinal glucose absorption. In contrast to other oral hypoglycemics, Metbay 500 Tablet PR monotherapy infrequently results in hypoglycemia due to its mechanism of preventing excessive insulin release. Beyond glycemic control, it also assists in weight management.
Metbay 500 Tablet PR is generally well-received and doesn't typically induce drowsiness. Infrequently, though, it may lead to sleep disturbances or insomnia. Excessive sleepiness can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or somnolence develops during Metbay 500 Tablet PR use.
Administer Metbay 500 Tablet PR orally, with or following a meal. The tablets should be swallowed whole with water; avoid crushing or chewing. For once-daily prescriptions, ingestion with breakfast is recommended. Twice-daily regimens should involve one tablet in the morning and one in the evening. Three times daily, distribute the tablets among breakfast, lunch, and dinner. Consuming Metbay 500 Tablet PR with food mitigates potential gastrointestinal distress, such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metbay 500 Tablet PR
17
MRP 20
14% off